7-Keto-DHEA: The Definitive Guide

What is 7-Keto-DHEA?

7-Keto-DHEA is a DHEA metabolite marketed for weight loss. Only four studies qualified for a 2023 systematic review, and WADA prohibits it at all times in 2026. No RDA, AI, UL or established weight-loss regimen exists for 7-keto-DHEA. It is prohibited at all times under the 2026 WADA Prohibited List. [1]

Typical 7-Keto-DHEA Protocols

These rows reproduce sources. Do not average them into one universal regimen.

Which forms and label details matter?

Record 7-keto-DHEA, 7-oxo-DHEA or 3-acetyl-7-oxo-DHEA identity, active milligrams, route and all thermogenic co-ingredients. DHEA, DHEA-S and 7-keto-DHEA are not interchangeable.

How should it be stored?

Follow the label, close the container and protect it from heat, light and moisture.

What is it commonly used for?

It is marketed for weight, metabolic rate and “adrenal” support. Evidence is sparse, short and usually combined with calorie restriction or exercise; adrenal-fatigue claims are not established.

What does human research show?

The 2023 systematic review found only four eligible studies from 686 records. Two reported significant weight loss, one a body-fat reduction and two a resting-metabolic-rate increase; studies lasted one to eight weeks and tested 102–200 mg/day, generally as 3-acetyl-7-keto-DHEA twice daily. The review concluded that evidence remained insufficient and called for larger, longer trials. [2] Kalman’s 30-person 2000 trial used 100 mg twice daily for eight weeks alongside diet and exercise. [3] Zenk’s trial used a multi-ingredient product, so it cannot isolate 7-keto-DHEA. [4] A later crossover tested short metabolic-rate changes, not durable weight loss. [5] WADA lists 7-Keto-DHEA among anabolic agents prohibited in and out of competition. [1]

How might it act?

7-keto-DHEA is a steroid metabolite studied for thermogenic-enzyme and resting-metabolic-rate effects. A short metabolic-rate change is a surrogate and does not establish durable fat loss or endocrine safety.

How does it compare with related products?

What are the risks and interactions?

Long-term endocrine, reproductive, liver and cardiovascular safety is insufficiently characterized. Avoid in pregnancy, breastfeeding, hormone-sensitive conditions and competitive sport. Review all medicines and supplements with a clinician; stop for chest pain, severe headache, jaundice or major mood changes.

Which medicines require review?

Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [6], [7]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.

Common questions about 7-Keto-DHEA

Is 7-keto-DHEA the same as DHEA?

No. They are distinct steroid-related compounds and evidence cannot be transferred.

Does it reliably cause weight loss?

No. The evidence base is only four short studies with mixed results.

Is 200 mg/day established?

No. It was a source-specific trial total, often alongside diet and exercise.

Can competitive athletes use it?

No under the 2026 WADA list; it is prohibited at all times.

Does it treat adrenal fatigue?

No established diagnosis or evidence supports that claim.

What should I track?

Exact chemical identity, amount each time, co-ingredients, sport status, weight outcome, symptoms and review date.

Glossary

Terms for reading the evidence.

Active amount

The declared amount of the ingredient of interest, distinct from total blend mass.

Daily total

The sum across administrations; it does not reveal amount each time.

Randomized trial

A study assigning an intervention and comparator by chance.

Surrogate outcome

A measure such as energy expenditure that is not weight loss itself.

Co-ingredient

Another active substance that can alter benefit or risk.

Clinical importance

Whether a measured difference is large enough to matter in practice.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources